清晰 发表于 2025-3-23 13:05:23

Submitted on: 09 October 2011.
Revised on: 17 December 2011.
Accepted on: 03 February 2012.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

吝啬性 发表于 2025-3-23 15:50:10

http://reply.papertrans.cn/1/57/5681/5681-12.png

翻布寻找 发表于 2025-3-23 18:37:51

http://reply.papertrans.cn/1/57/5681/5681-13.png

predict 发表于 2025-3-23 23:14:59

http://reply.papertrans.cn/1/57/5681/5681-14.png

消灭 发表于 2025-3-24 06:23:33

Submitted on: 07 November 2002.
Revised on: 05 March 2003.
Accepted on: 22 April 2003.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

cajole 发表于 2025-3-24 10:17:00

http://reply.papertrans.cn/1/57/5681/5681-16.png

无畏 发表于 2025-3-24 13:36:28

http://reply.papertrans.cn/1/57/5681/5681-17.png

EXCEL 发表于 2025-3-24 18:16:14

http://reply.papertrans.cn/1/57/5681/5681-18.png

突变 发表于 2025-3-24 22:27:51

Submitted on: 30 August 2005.
Revised on: 17 December 2005.
Accepted on: 04 January 2006.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

Phonophobia 发表于 2025-3-25 02:54:17

http://reply.papertrans.cn/1/57/5681/5681-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊CLINICAL NEUROPHARMACOLOGY 2024/2025影响因子:0.816 (CLIN NEUROPHARMACOL) (0362-5664). (CLINICAL NEUROLOGY)(临床神经病学)Sci